NDAORALSUSPENSION
Approved
Aug 2000
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 7h ago · AI intelligence enriched Yesterday
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Children's Motrin Cold is a fixed-dose combination of ibuprofen (NSAID) and pseudoephedrine hydrochloride (decongestant) formulated as an oral suspension for pediatric patients. It treats cold and flu symptoms including fever, pain, and nasal congestion in children. The ibuprofen reduces fever and pain while pseudoephedrine relieves nasal congestion.
LOE Approaching
Mature product approaching loss of exclusivity signals transition planning and potential team restructuring or consolidation within commercial operations.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Children's Motrin Cold offers limited career growth opportunities given the product's LOE-approaching status and minimal job openings. Roles would primarily focus on managing decline, optimizing existing commercial operations, and preparing transition strategies rather than driving innovation or expansion.
Brand ManagerProduct Manager
Worked on CHILDREN'S MOTRIN COLD at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.